How does bench science get to the bedside? Now, more than ever, understanding how NIH-funded basic science research leads to groundbreaking medical treatments is crucial.
Richard Lifton, an internationally renowned genetics researcher and president of Rockefeller University, will discuss the translation of fundamental discoveries into therapeutic innovations, bridging the gap between laboratory research and clinical applications. Attendees will gain insights into the funding process, the challenges of therapeutic development, and the impact of scientific advancements on public health.
Dr. Lifton will also speak at a celebration of the life and career of the late DOM chair Dr. Floyd Rector, from 2pm - 5pm on Tuesday, April 1, also in HSW-300. Further information on the Rector event can be found here.
Speaker: Richard Lifton, MD, PhD, is the president of The Rockefeller University, the former chair of Genetics at Yale University, and the founder of the Yale Center for Genome Analysis. He serves as a director at Roche and its subsidiary, Genentech. Lifton has also served on the Advisory Council to the NIH Director, co-chaired the National Academy of Sciences and Royal Society's International Commission on the Clinical Use of Germline Genome Editing, and co-chaired the White House and NIH's Precision Medicine Planning Group. He was awarded the Breakthrough Prize in Life Sciences and the Association of American Physicians' Kober Medal.
How to Attend
In Person:
HSW-300 (Medical Sciences Building)
Lunch will be provided
By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599
International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc
Add to Calendar2025-04-01 19:00:002025-04-01 20:00:00The Path From NIH Funding of Basic Science to New Therapeutics
The Path From NIH Funding of Basic Science to New Therapeutics
Richard Lifton, MD, PhD
Session moderated by Bob Wachter
How does bench science get to the bedside? Now, more than ever, understanding how NIH-funded basic science research leads to groundbreaking medical treatments is crucial.
Richard Lifton, an internationally renowned genetics researcher and president of Rockefeller University, will discuss the translation of fundamental discoveries into therapeutic innovations, bridging the gap between laboratory research and clinical applications. Attendees will gain insights into the funding process, the challenges of therapeutic development, and the impact of scientific advancements on public health.
Dr. Lifton will also speak at a celebration of the life and career of the late DOM chair Dr. Floyd Rector, from 2pm - 5pm on Tuesday, April 1, also in HSW-300. Further information on the Rector event can be found here.
Speaker:
Richard Lifton, MD, PhD, is the president of The Rockefeller University, the former chair of Genetics at Yale University, and the founder of the Yale Center for Genome Analysis. He serves as a director at Roche and its subsidiary, Genentech. Lifton has also served on the Advisory Council to the NIH Director, co-chaired the National Academy of Sciences and Royal Society's International Commission on the Clinical Use of Germline Genome Editing, and co-chaired the White House and NIH's Precision Medicine Planning Group. He was awarded the Breakthrough Prize in Life Sciences and the Association of American Physicians' Kober Medal.
How to Attend
In Person:
HSW-300 (Medical Sciences Building)
Lunch will be provided
On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/97645766587?pwd=OpxbkAwpMENJgLN8xpPHofjwzHD8JH.1
Webinar ID: 976 4576 6587
Passcode: 364678
By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599
International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc
The session will be recorded for later play. See all past recordings.
Department of MedicineAmerica/Los_Angelespublic
